Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citationLong-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Self-citationPulmonary Arterial Hypertension
Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A. E., Barst, R. J., Benza, R. L., Liou, T. G., Turner, M., et al. (2010) · Chest · doi:10.1378/chest.09-1140 · Cited by 1,178
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Gomez Sanchez, M. A., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138
Pepke-Zaba, J., Delcroix, M., Lang, I., Mayer, E., Jansa, P., Ambroz, D., Treacy, C., D'Armini, A. M., Morsolini, M., Snijder, R., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015008 · Cited by 1,059
Self-citationPulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Kovacs, G., Berghold, A., Scheidl, S., & Olschewski, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00145608 · Cited by 1,057
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Diagnosis and differential assessment of pulmonary arterial hypertension
Barst, R. J., McGoon, M., Torbicki, A., Sitbon, O., Krowka, M. J., Olschewski, H., & Gaine, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.032 · Cited by 992
Self-citationPulmonary hypertension in chronic lung disease and hypoxia
Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01914-2018 · Cited by 757
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Self-citationRosenzweig, E. B., Abman, S. H., Adatia, I., Beghetti, M., Bonnet, D., Haworth, S., Ivy, D. D., & Berger, R. M. F. (2019) · European Respiratory Journal · doi:10.1183/13993003.01916-2018 · Cited by 628
Pulmonary hypertension due to left heart disease
Vachiéry, J.-L., Tedford, R. J., Rosenkranz, S., Palazzini, M., Lang, I., Guazzi, M., Coghlan, G., Chazova, I., & De Marco, T. (2019) · European Respiratory Journal · doi:10.1183/13993003.01897-2018 · Cited by 555
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 512
Self-citationEIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Eyries, M., Montani, D., Girerd, B., Perret, C., Leroy, A., Lonjou, C., Chelghoum, N., Coulet, F., Bonnet, D., Dorfmüller, P., et al. (2014) · Nature Genetics · doi:10.1038/ng.2844 · Cited by 452
Self-citationLong-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Self-citationMontani, D., Achouh, L., Dorfmüller, P., Le Pavec, J., Sztrymf, B., Tchérakian, C., Rabiller, A., Haque, R., Sitbon, O., Jaïs, X., et al. (2008) · Medicine · doi:10.1097/md.0b013e31818193bb · Cited by 355
Self-citationPulmonary Veno-occlusive Disease
MANDEL, J., MARK, E. J., & HALES, C. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912045 · Cited by 297
Exercise-induced Pulmonary Hypertension: Physiological Basis and Methodological Concerns
Naeije, R., Vanderpool, R., Dhakal, B. P., Saggar, R., Saggar, R., Vachiery, J.-L., & Lewis, G. D. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2090ci · Cited by 285
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Fonseca, G. H. H., Souza, R., Salemi, V. M. C., Jardim, C. V. P., & Gualandro, S. F. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00134410 · Cited by 274
Self-citationOutcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
Taboada, D., Pepke-Zaba, J., Jenkins, D. P., Berman, M., Treacy, C. M., Cannon, J. E., Toshner, M., Dunning, J. J., Ng, C., Tsui, S. S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00050114 · Cited by 258
Guidelines for the diagnosis and treatment of pulmonary hypertension
Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., Gibbs, J. S., et al. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2011.10.006 · Cited by 257
Self-citationCriteria for diagnosis of exercise pulmonary hypertension
Herve, P., Lau, E. M., Sitbon, O., Savale, L., Montani, D., Godinas, L., Lador, F., Jaïs, X., Parent, F., Günther, S., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00021915 · Cited by 251
Self-citationSurvival in Sarcoidosis-Associated Pulmonary Hypertension
Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010) · Chest · doi:10.1378/chest.09-2002 · Cited by 234
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
Mehari, A., Gladwin, M. T., Tian, X., Machado, R. F., & Kato, G. J. (2012) · JAMA · doi:10.1001/jama.2012.358 · Cited by 229
Splenectomy and chronic thromboembolic pulmonary hypertension
Jais, X. (2005) · Thorax · doi:10.1136/thx.2004.038083 · Cited by 228
Self-citationMild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality
Douschan, P., Kovacs, G., Avian, A., Foris, V., Gruber, F., Olschewski, A., & Olschewski, H. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1215oc · Cited by 215
Montani, D., Girerd, B., Jaïs, X., Levy, M., Amar, D., Savale, L., Dorfmüller, P., Seferian, A., Lau, E. M., Eyries, M., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30438-6 · Cited by 190
Self-citationValerio, C. J., Schreiber, B. E., Handler, C. E., Denton, C. P., & Coghlan, J. G. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37838 · Cited by 183
Self-citationChronic Cor Pulmonale, Report of an Expert Committee
(1961) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1961.tb69869.x · Cited by 181
Pulmonary Hypertension after Splenectomy?
Hoeper, M. M., Niedermeyer, J., Hoffmeyer, F., Flemming, P., & Fabel, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00014 · Cited by 179
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Boucly, A., Cottin, V., Nunès, H., Jaïs, X., Tazi, A., Prévôt, G., Reynaud‐Gaubert, M., Dromer, C., Viacroze, C., Horeau-Langlard, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00465-2017 · Cited by 159
Self-citationEarly detection of pulmonary arterial hypertension
Lau, E., Humbert, M. J. C., & Celermajer, D. S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.191 · Cited by 158
Self-citationFeatures and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension
Zamanian, R. T., Hedlin, H., Greuenwald, P., Wilson, D. M., Segal, J. I., Jorden, M. A., Kudelko, K. T., Liu, J., Hsi, A., Rupp, A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0943oc · Cited by 149
Hadinnapola, C., Bleda, M., Haimel, M., Screaton, N., Swift, A., Dorfmüller, P., Preston, S. D., Southwood, M., Hernandez-Sanchez, J., Martin, J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028351 · Cited by 147
Self-citationLong-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Weatherald, J. C., Chaumais, M., Savale, L., Jaïs, X., Seferian, A., Canuet, M., Bouvaist, H., Magro, P., Bergeron, A., Guignabert, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00217-2017 · Cited by 146
Self-citationCardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Niss, O., Quinn, C. T., Lane, A., Daily, J., Khoury, P. R., Bakeer, N., Kimball, T. R., Towbin, J. A., Malik, P., & Taylor, M. D. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.05.013 · Cited by 142
Tedford, R. J., Beaty, C. A., Mathai, S. C., Kolb, T. M., Damico, R. L., Hassoun, P. M., Leary, P. J., Kass, D. A., & Shah, A. S. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.11.008 · Cited by 141
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease
Montani, D., Lau, E., Descatha, A., Jaïs, X., Savale, L., Andujar, P., Bensefa‐Colas, L., Girerd, B., Zendah, I., Pavec, J. L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00814-2015 · Cited by 136
Self-citationDerchi, G., Galanello, R., Bina, P., Cappellini, M. D., Piga, A. G., Lai, M.-E., Quarta, A., Casu, G., Perrotta, S., Pinto, V. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002124 · Cited by 127
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Coghlan, G., Wolf, M., Distler, O., Denton, C. P., Doelberg, M., Harutyunova, S., Marra, A. M., Benjamin, N., Fischer, C., & Grünig, E. (2018) · European Respiratory Journal · doi:10.1183/13993003.01197-2017 · Cited by 118
Self-citationBMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Ghigna, M., Guignabert, C., Montani, D., Girerd, B., Jaïs, X., Savale, L., Hervé, P., de Montpréville, V., Mercier, O. M., Sitbon, O., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00464-2016 · Cited by 109
Self-citationPulmonary Hypertension and Thyroid Disease
Li, J. H., Safford, R. E., Aduen, J. F., Heckman, M. G., Crook, J. E., & Burger, C. D. (2007) · CHEST Journal · doi:10.1378/chest.07-0366 · Cited by 103
Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases
Weitzenblum, E., Chaouat, A., Canuet, M., & Kessler, R. (2009) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1233315 · Cited by 99
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension
Hemnes, A. R., Zhao, M., West, J. D., Newman, J. H., Rich, S., Archer, S. L., Robbins, I. M., Blackwell, T. S., Cogan, J. D., Loyd, J. E., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1678oc · Cited by 97
Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension
Hemnes, A. R., Trammell, A. W., Archer, S. L., Rich, S., Yu, C., Nian, H., Penner, N. L., Funke, M., Wheeler, L. A., Robbins, I. M., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.013317 · Cited by 95
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients
Cottin, V., Harari, S. A., Humbert, M. J. C., Mal, H., Dorfmüller, P., Jaïs, X., Reynaud‐Gaubert, M., Prévôt, G., Lazor, R., Taillé, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00093111 · Cited by 95
Self-citationPrimary pulmonary hypertension.
Hatano, K. (1975) · Medical Entomology and Zoology · Cited by 95
Bishop, J. M., & Cross, K. W. (1984) · PubMed · Cited by 93
Nossent, E. J., Antigny, F., Montani, D., Bogaard, H. J., Ghigna, M., Lambert, M., de Montpréville, V., Girerd, B., Jaïs, X., Savale, L., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.09.022 · Cited by 74
Self-citationRiou, M., Seferian, A., Savale, L., Chaumais, M., Guignabert, C., Canuet, M., Magro, P., Réa, D., Sitbon, O., Jaïs, X., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01410-2016 · Cited by 67
Self-citationChronic cor pulmonale. Report of an expert committee
(1961) · PubMed · Cited by 63
Redefining pulmonary hypertension
Maron, B. A., Brittain, E. L., Choudhary, G., & Gladwin, M. T. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30498-8 · Cited by 58
Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir
Renard, S., Borentain, P., Salaün, E., Benhaourech, S., Maille, B., Darque, A., Brégigeon, S., Colson, P., Laugier, D., Reynaud‐Gaubert, M., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.09.018 · Cited by 55
Freitas, C. S. G., Baldi, B. G., Jardim, C., Araújo, M. S., Sobral, J. B., Heiden, G. I., Kairalla, R. A., Souza, R., & de Carvalho, C. R. R. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0626-0 · Cited by 52
Self-citationBosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension
Hickey, P. M., Thompson, A. A. R., Charalampopoulos, A. F., Elliot, C. A., Hamilton, N., Kiely, D. G., Lawrie, A., Sabroe, I., & Condliffe, R. A. (2016) · European Respiratory Journal · doi:10.1183/13993003.01004-2016 · Cited by 50
Teawtrakul, N., Jetsrisuparb, A., Pongudom, S., Sirijerachai, C., Chansung, K., Wanitpongpun, C., & Fucharoen, S. (2017) · Hematology · doi:10.1080/10245332.2017.1358845 · Cited by 49
Lau, E., Vanderpool, R. R., Choudhary, P., Simmons, L. R., Corte, T. J., Argiento, P., D’Alto, M., Naeije, R., & Celermajer, D. S. (2014) · CHEST Journal · doi:10.1378/chest.13-2300 · Cited by 47
Self-citationChinese herbal drug natural indigo may cause pulmonary artery hypertension
Nishio, M., Hirooka, K., & Doi, Y. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw090 · Cited by 46
Humbert, M. J. C., Khaltaev, N., Bousquet, J. J., & Souza, R. (2007) · CHEST Journal · doi:10.1378/chest.07-0903 · Cited by 44
Self-citationLau, E., Bailey, D. L., Bailey, E. A., Torzillo, P. J., ROACH, P. J., Schembri, G. P., Corte, T. J., & Celermajer, D. S. (2013) · Heart · doi:10.1136/heartjnl-2013-304254 · Cited by 39
Self-citationSouza, R., Fernandes, C. J. C. D. S., & Jardim, C. (2009) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1233314 · Cited by 37
Self-citationSeegobin, K., Babbar, A., Ferreira, J., Lyons, B., Cury, J., & Seeram, V. K. (2017) · Pulmonary Circulation · doi:10.1177/2045893217733444 · Cited by 37
Sarcoidosis-Associated Pulmonary Hypertension
Shlobin, O. A., & Baughman, R. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1603767 · Cited by 36
The prognostic impact of thyroid function in pulmonary hypertension
Richter, M. J., Sommer, N., SCHERMULY, R. T., Grimminger, B., Seeger, W., Tello, K., Ghofrani, H. A., & Gall, H. J. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.05.022 · Cited by 36
Tsitsikas, D. A., Sirigireddy, B., Nzouakou, R., Calvey, A., Quinn, J., Collins, J., Orebayo, F., Lewis, N., Todd, S., & Amos, R. J. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21447 · Cited by 30
Leflunomide-Induced Pulmonary Hypertension in a Young Woman with Rheumatoid Arthritis: A Case Report
Alvarez, P. A., Saad, A. K., Flagel, S., Mazzocchi, O., & Blanco, M. V. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9153-3 · Cited by 25
Pulmonary endarterectomy for chronic thromboembolic disease
Yıldızeli, Ş. O. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.37929 · Cited by 25
Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide
Martínez-Taboada, V., Rodriguez-Valverde, V., Gonzalez-Vilchez, F., & Armijo, J. A. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh328 · Cited by 24
Pulmonary arterial hypertension in four patients treated by leflunomide
Coirier, V., Lescoat, A., Chabanne, C., Fournet, M., Coiffier, G., Jouneau, S., Polard, É., & Jégo, P. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.12.014 · Cited by 21
Wu, X., Xu, W., Wang, J., Tian, X., Tian, Z., & Xu, K. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0634-z · Cited by 18
Under Pressure to Clarify Pulmonary Hypertension Clinical Risk
Maron, B. A., Wertheim, B. M., & Gladwin, M. T. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2306ed · Cited by 17
Pulmonary hypertension in sickle cell disease
da Fonseca, G. W. P., & Souza, R. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000200 · Cited by 15
Self-citationSavale, L., Chaumais, M., Montani, D., Jaïs, X., Hézode, C., Antonini, T., Coilly, A., Duclos‐Vallée, J., Samuel, D., Simonneau, G., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.04.031 · Cited by 15
Self-citationIdentifying early pulmonary arterial hypertension in patients with systemic sclerosis
Condliffe, R. A., & Kovács, G. (2018) · European Respiratory Journal · doi:10.1183/13993003.00495-2018 · Cited by 15
[Pulmonary hypertension following appetite depressants].
Hp, G. (1972) · PubMed · Cited by 10
Mehari, A., Thomas, A. V., Thomas, A. N., & Johnson, M. S. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.4.545 · Cited by 8
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2020 ESC Guidelines for the management of adult congenital heart disease
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa554 · Cited by 2,311
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.